Tomizawa K - Search Results

1

Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer.

Suda K, Murakami I, Sakai K, Tomizawa K, Mizuuchi H, Sato K, Nishio K, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. Lung Cancer. 2016 Jan;91:36-40. doi: 10.1016/j.lungcan.2015.11.016. Epub 2015 Nov 25. Lung Cancer. 2016. PMID: 26711932

2

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.

Suda K, Tomizawa K, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. Cancer Metastasis Rev. 2010 Mar;29(1):49-60. doi: 10.1007/s10555-010-9209-4. Cancer Metastasis Rev. 2010. PMID: 20108024 Review.

3

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.

Tomizawa K, Suda K, Onozato R, Kuwano H, Yatabe Y, Mitsudomi T. Tomizawa K, et al. J Thorac Oncol. 2010 Nov;5(11):1859-61. doi: 10.1097/JTO.0b013e3181f1c433. J Thorac Oncol. 2010. PMID: 20975381 Free article.

4

Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.

Suda K, Murakami I, Katayama T, Tomizawa K, Osada H, Sekido Y, Maehara Y, Yatabe Y, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. Clin Cancer Res. 2010 Nov 15;16(22):5489-98. doi: 10.1158/1078-0432.CCR-10-1371. Epub 2010 Nov 9. Clin Cancer Res. 2010. PMID: 21062933

5

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.

Tomizawa K, Suda K, Onozato R, Kosaka T, Endoh H, Sekido Y, Shigematsu H, Kuwano H, Yatabe Y, Mitsudomi T. Tomizawa K, et al. Lung Cancer. 2011 Oct;74(1):139-44. doi: 10.1016/j.lungcan.2011.01.014. Epub 2011 Feb 25. Lung Cancer. 2011. PMID: 21353324

6

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.

Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. J Thorac Oncol. 2011 Jul;6(7):1152-61. doi: 10.1097/JTO.0b013e318216ee52. J Thorac Oncol. 2011. PMID: 21597390 Free article.

7

Lung cancers unrelated to smoking: characterized by single oncogene addiction?

Suda K, Tomizawa K, Yatabe Y, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. Int J Clin Oncol. 2011 Aug;16(4):294-305. doi: 10.1007/s10147-011-0262-y. Epub 2011 Jun 8. Int J Clin Oncol. 2011. PMID: 21655907

8

Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation.

Suda K, Tomizawa K, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. Lung Cancer. 2012 Jun;76(3):292-9. doi: 10.1016/j.lungcan.2011.11.007. Epub 2011 Nov 30. Lung Cancer. 2012. PMID: 22133747

9

Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene.

Fukui T, Yatabe Y, Kobayashi Y, Tomizawa K, Ito S, Hatooka S, Matsuo K, Mitsudomi T. Fukui T, et al. Among authors: tomizawa k. Lung Cancer. 2012 Aug;77(2):319-25. doi: 10.1016/j.lungcan.2012.03.013. Epub 2012 Apr 6. Lung Cancer. 2012. PMID: 22483782

10

Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.

Suda K, Tomizawa K, Mizuuchi H, Ito S, Kitahara H, Shimamatsu S, Kohno M, Yoshida T, Okamoto T, Maehara Y, Yatabe Y, Mitsudomi T. Suda K, et al. Among authors: tomizawa k. Aging Dis. 2012 Dec;3(6):438-43. Epub 2012 Oct 23. Aging Dis. 2012. PMID: 23251849 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters